Skip to main content

Advertisement

Log in

Secondary Amyloidosis has Decreased in Patients with Inflammatory Joint Disease in Finland

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract:

We studied whether the high incidence of secondary amyloidosis (SA) is a consistent finding in patients with inflammatory joint disease. A total of 4508 biopsies of patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis were studied at the Rheumatism Foundation Hospital during 1987–1997. The results show that the annual number of findings of SA was reduced from 68 to less than 10. We suggest that a change in medication towards more frequent use of cytostatic agents is the reason for the reduction in incidence of SA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 10 April 1998 / Accepted: 23 September 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laiho, K., Tiitinen, S., Kaarela, K. et al. Secondary Amyloidosis has Decreased in Patients with Inflammatory Joint Disease in Finland. Clin Rheumatol 18, 122–123 (1999). https://doi.org/10.1007/s100670050068

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100670050068

Navigation